MRI in residual tumor size measurement in patient with breast cancer receiving neoadjuvant chemotherapy calls for caution

Breast Cancer Research and Treatment

Volumn 135, Issue 1, 2012, Pages 319-320

  Wu, Lian Ming ^a   Hu, Jiani ^b   Xu, Jian Rong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER REGRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FALSE NEGATIVE RESULT; HISTOPATHOLOGY; HUMAN; LETTER; MINIMAL RESIDUAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT ASSESSMENT; PATIENT SAFETY; PREDICTION; PRIORITY JOURNAL; TREATMENT RESPONSE; TUMOR VOLUME;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; NEOADJUVANT THERAPY; NEOPLASM, RESIDUAL;

EID: 84865152232     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2182-6     Document Type: Letter

References (7)

1. Wu LM, Hu JN, Gu HY, Hua J, Chen J, Xu JR (2012) Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer? Breast Cancer Res Treat. doi: 10.1007/s10549-012-2033-5
2. Wasser K, Sinn HP, Fink C et al (2003) Accuracy of tumor size measurement in breast cancer using MRI is influenced by histological regression induced by neoadjuvant chemotherapy. Eur Radiol 13:1213-1223 (Pubitemid 36790621)
3. Nakahara H, Yasuda Y, Machida E et al (2011) MR and US imaging for breast cancer patients who underwent conservation surgery after neoadjuvant chemotherapy: comparison of triple negative breast cancer and other intrinsic subtypes. Breast Cancer 18(3):152-160
4. Warren RM, Bobrow LG, Earl HM et al (2004) Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy? Br J Cancer 90(7):1349-1360 (Pubitemid 38586259)
5. Rieber A, Brambs HJ, Gabelmann A, Heilmann V, Kreienberg R, Kühn T (2002) Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy. Eur Radiol 12(7):1711-1719 (Pubitemid 36940255)
6. Rieber A, Zeitler H, Rosenthal H, Görich J, Kreienberg R, Brambs HJ, Tomczak R (1997) MRI of breast cancer: influence of chemotherapy on sensitivity. Br J Radiol 70(833):452-458 (Pubitemid 27229264)
7. Dinnes J, Deeks J, Kirby J, Roderick P (2005) A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy. Health Technol Assess 9(12):1-113